Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-056092

CBO & COO gave up 4,207 shares (to pay taxes)

  • CBO & COO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2021-09-10 Option exercise +10,000 11,050 D
Klein Lawrence Otto CBO & COO 2021-09-13 Shares withheld for taxes −4,207 $117.86 $495,837 6,843 D
Derivatives
Klein Lawrence Otto CBO & COO 2021-09-10 Shares withheld for taxes · Restricted Stock Units −10,000 0 D
Loading xslF345X03/doc4.xml…